Need of new clinical criteria for the identification of genetic lynch syndrome;Necessidade de novos critérios clínicos: Para a identificação de famílias com síndroma de lynch em base genética

Acta Medica Portuguesa

Volumn 20, Issue 6, 2007, Pages 535-541

  Sousa, Rita ^a   Lage, Pedro ^a   Ferreira, Sara ^a   Claro, Isabel ^a   Francisco, Inês ^a   Filipe, Bruno ^a   Albuquerque, Cristtna ^a   Suspiro, Alexandra ^a   Rodrigues, Paula ^a   Nobre Leitão, Carlos ^a  

^a INSTITUTO PORTUGUÊS DE ONCOLOGIA DE LISBOA FRANCISCO GENTIL   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FAMILIAL CANCER; FAMILY; GENE MUTATION; GENE SEQUENCE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MISMATCH REPAIR;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; MUTATION;

EID: 41149149338     PISSN: None     EISSN: 16460758     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. AALTONEN LA, SALOVAARA R, KRISTO P et al: Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med 1998;338:1481-7
2. LYNCH HT, LANSPA S, SMYRK T et al: Hereditary nonpolyposis colorectal cancer (Lynch Syndromes I &∂ II). Genetics, pathology, natural history and cancer control, Part I. Cancer Genet Cytogenet 1991;53:143-60
3. WATSON P, LYNCH HT: Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer 1993;71:677-85
4. VASEN HFA, WIJNEN JT, MENKO FH et al: Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterol 1996;110:1020-7
5. PAPADOULOS N, LINDBLOM A: Molecular basis of HNPCC: mutations of MMR genes. Hum Mutat 1997;10:89-99
6. SCAPOLI C, LEON M, SASSATELLI R et al : Genetic epidemiology of hereditary non-polyposis colorectal cancer syndromes in Modena, Italy: results of a complex segregation analysis. Ann Hum Genet 1994;58:275-295
7. JÄRVINEN H, AARNIO M, MUSTONEN H et al: Controlled 15-Year Trial on Screening for Colorectal Cancer in Families with Hereditary Nonpolyposis Colorectal Cancer. Gastroenterol 2000;118:829-834
8. VASEN HF, MECKLIN JP, KHAN PM, LYNCH HT: The International Collaborative Group on Hereditary Non-polyposis Colorectal Cancer. Dis Colon Rectum 1991;34:424-425
9. VASEN HF, WATSON P, MECKLIN JP, LYNCH HT: New clinical criteria for hereditary nonpolyposis colorectal cancer proposed by the International Collaborative Group on HNPCC. Gastroenterol 1999;116:1453-6
10. RODRIGUEZ-BIGAS MA, BOLAND CR, HAMILTON SR et al: A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda Guidelines. J Natl Cancer Inst 1997;89:1758-62
11. AALTONEN LA, PELTOMÄKI P, MECKLIN JP et al: Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients. Cancer Res 1994;54:1645-8
12. NYSTROM-LAHTI M, WU Y, MOISIO AL et al: DNA mismatch repair gene mutations in 55 kindreds with verified or putative hereditary non-polyposis colorectal cancer. Hum Mol Genet 1996;5:763-9
13. WU Y, NYSTROM-LAHTI M, OSINGA J et al: MSH2 and MLHl mutations in sporadic replication error-positive colorectal carcinoma as assessed by two-dimensional DNA electrophoresis. Genes Chromosomes Cancer 1997;18:269-278
14. WU Y, BERENDS M, MENSINK R et al: Association of Hereditary Nonpolyposis Colorectal Cancer-related Tumors Displaying Low Microsatellite Instability with MSH6 Germline Mutations. Am J Hum Genet 1999;65:1291-8
15. PELTOMÄKI P, VASEN HF: Mutations predisposing to hereditary nonpolyposis colorectal cancer. Database and results of a collaborative study. The International Collaborative Group on Hereditary Nonpolpyposis Colorectal Cancer. Gastroenterol 1997;113:146-158
16. BOLAND CR, THIBODEAU SN, HAMILTON SR et al: A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998;58:5248-57
17. BARNETSON RA, TENESAA, FARRINGTON SM et al: Identification and Survival of Carriers of Mutations in DNA Mismatch-repair Genes in Colon Cancer. N Engl J Med 2006;354:2751-63
18. SALOVAARA R, LOUKOLAA, KRISTO P et al: Populationbased molecular detection of hereditary nonpolyposis colorectal cancer. J Clin Oncol 200;18(11):2193-200
19. HAMPEL H, FRANKEL W, MARTIN E et al: Screening for the Lynch Syndrome. N Engl J Med 2005;352:1851-60
20. TERDIMAN JP, GUM JR, CONRAD PG et al: Efficient detection of hereditary nonpolyposis colorectal cancer gene carriers by screening for tumor microsatellite instability before germline genetic testing. Gastroenterol 2001;120:21-30
21. LAGERSTEDT RK, LIU T, VANDROVCOVA J et al: Lynch Syndrome (hereditary nonpolyposis colorectal cancer) diagnostics. J Natl Cancer Inst 2007; 99(4):291-9
22. JASS JR: Hereditary Non-Polyposis Colorectal Cancer: the rise and fall of a confusing term. World J Gastroenterol 2006;12(31):4943-50
23. AALTONEN LA, PELTOMÄKI P, LEACH FS et al: Clues to the Pathogenesis of Familial Colorectal Cancer. Science 1993;260:812-6
24. LYNCH HT, LYNCH J: Lynch Syndrome: Genetics, natural history, genetic counselling and prevention. J Clin Oncol 2000;18:19S-31S
25. LYNCH H, CHAPELLE A: Hereditary Colorectal Cancer. N Engl J Med 2003;348:919-932
26. SYNGAL S, FOX EA, LI C et al: Interpretation of genetic test results for hereditary nonpolyposis colorectal cancer: Implications for clinical predisposition testing. JAMA 1999;282(2):247253
27. WIJNEN JT, VASEN HF, KHAN PM et al: Clinical findings with implications for genetic testing in families with clustering of colorectal cancer. N Engl J Med 1998;339(8):511-8
28. PALMIROTTA R, MATERA S, CURIA MC et al: Correlations between phenotype and microsatellite instability in HNPCC: Implications for Genetic Testing. Fam Cancer 2004;3(2):117-121
29. RODRIGUEZ-MORANTA F, CASTELLS A, ANDREU M et al: Clinical Performance of original and Revised Bethesda Guidelines for the Identification of MSH2/MLH1 Gene Carriers in Patients with Newly Diagnosed Colorectal Cancer: Proposal of a New and Simpler Set of Recommendations. Am J Gastroenterol 2006; 101:1104-11